This is fibroblast activation translating into early collagen deposition
The convenience of a single injection is real
Phase 3 clinical results, led largely by the OASIS 4 trial, show that participants who took the pill alongside lifestyle changes achieved an average weight loss of 16-17% after more than a year of treatment - figures that rival those of the injectable version
MASH is rarely an isolated condition, and treating MASH often requires multidisciplinary collaboration
Clinicians often integrate the product with calorie-restricted diets, resistance training, and behavior-change counseling to potentially maximize adipose mass reduction while preserving lean tissue, though evidence remains largely extrapolated from the individual components pharmacology and not from randomized controlled trials of the exact compounded combination
Promotes fullness by slowing digestion, helping patients feel satisfied with smaller meals